Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044978
Filing Date
2024-11-13
Accepted
2024-11-13 08:30:37
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 556479
2 ex3-1.htm EX-3.1 29544
3 ex31-1.htm EX-31.1 11839
4 ex31-2.htm EX-31.2 11921
5 ex31-3.htm EX-31.3 12106
6 ex32-1.htm EX-32.1 10617
7 form10-q_001.jpg GRAPHIC 67175
  Complete submission text file 0001493152-24-044978.txt   3765715

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE cocp-20240930.xsd EX-101.SCH 28803
9 XBRL CALCULATION FILE cocp-20240930_cal.xml EX-101.CAL 39881
10 XBRL DEFINITION FILE cocp-20240930_def.xml EX-101.DEF 111690
11 XBRL LABEL FILE cocp-20240930_lab.xml EX-101.LAB 311857
12 XBRL PRESENTATION FILE cocp-20240930_pre.xml EX-101.PRE 236917
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 380136
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 241451328
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)